| ID ▲ | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 304 | Afp down + zwduur | Serum |
43 (1,8) | – | – | – | › | |||
| 1254 | alfa 1 glycoproteine | Serum |
2× per week | – | – µg/mL | – g/L | › | |||
| 1313 | Antithrombine (dier) | Citraat |
maandag t/m vrijdag | 67 (2,8) | – | – % | – | › | ||
| 1342 | anti-factor Xa | Citraat |
1× per week | 96 (4) | – | 3216-9 IU/ml | – | › | ||
| 1343 | anti-Xa Rivaroxaban Anti-Xa (New Oral AntiCoagulants) | Citraat |
1× per week | – | 74871-5 ng/mL | – | › | |||
| 1344 | Anti-Xa Apixaban | Citraat |
maandag t/m vrijdag | 18 (0,7) | – | 74214-8 ng/mL | – | › | ||
| 2592 | anti-IA2 antilichamen | Serum |
1× per maand | 909 (37,9) | – | 31209-0 U/mL | – | › | ||
| 2642 | Aminozuren kwantitatief | Heparine (Lithium-heparinebuis) |
2× per week | 303 (12,6) | – | 1913-3 | 35083-5 | › | ||
| 2655 | alfa Galactosidase | EDTA |
1× per week | 308 (12,9) | – | 1813-5 µmol/L/h | – | › | ||
| 3144 | A.N.A. (hond) | Serum |
1× per week | – | – | – | › | |||
| 3147 | A.N.A. kat | Serum |
141 (5,9) | – | – | – | › | |||
| 3199 | Anaplasma phagocyt.paard | Serum |
maandag t/m vrijdag | 153 (6,4) | – | – | – | › | ||
| 3221 | Acetylchol. rec. As dier Myasthenia gravis antistoffen | Serum |
395 (16,5) | – | – nmol/l | – | › | |||
| 3242 | anti-MAG As Myeline geassocieerde glycoproteïne antistoffen | Serum |
873 (36,4) | – | 31023-5 | – | › | |||
| 3258 | anti-ganglioside AS | Serum |
667 (27,8) | – | 82455-7 | – | › | |||
| 3277 | anti-MuSK As Anti-muscle specific kinase antistoffen | Serum |
278 (11,6) | – | 94273-0 | – | › | |||
| 3306 | anti-glycine receptor As | Serum |
319 (13,3) | – | 95722-5 | – | › | |||
| 3313 | Anti-nucleosomen | Serum |
– | 53014-7 U/ml | – | › | ||||
| 3314 | Anti-histonen | Serum |
– | 17380-7 U/ml | – | › | ||||
| 3316 | anti-VGCC (Ca kanaal As) | Serum |
412 (17,2) | – | 31024-3 pmol/L | – | › | |||
| 4310 | Ascaris As. | Serum |
1× per 2 weken | 327 (13,6) | – | 26671-8 | – | › | ||
| 4328 | Anisakis (ELISA) Haringwormziekte antistoffen | Serum |
1× per 2 weken | 197 (8,2) | – | – | – | › | ||
| 4390 | Anaplasma phagocytophilum | Serum |
– | – | – | › | ||||
| 4412 | Adenovirus 1 paard PCR | eSwab (Wissers varia / Overig) |
1× per week | – | – | – | › | |||
| 4434 | Angiostrong. vasorum PCR | Faeces |
maandag t/m vrijdag | 138 (5,8) | – | – | – | › | ||
| 4457 | Aspergillus Fumigatus PCR | eSwab (Wissers varia / Overig) |
maandag t/m vrijdag | 116 (4,8) | – | – | – | › | ||
| 4458 | Anaplasma platys PCR | EDTA |
1× per week | 143 (6) | – | – | – | › | ||
| 4484 | anti Delta As Hepatitis D virus As | Serum |
312 (13) | – | 95141-8 | – | › | |||
| 4773 | Afrikaanse paardenpest | Serum |
– | – | – | › | ||||
| 5608 | Aripiprazol Abilify | Serum |
1× per 1–2 weken | 216 (9) | – | 74931-7 µg/L | – | › | ||
| 5613 | Aripiprazol/dehydroapipr. | Serum |
232 (9,7) | – | – | – | › | |||
| 5978 | Amikacine Dal Amukin | Serum |
291 (12,1) | – | 3321-7 mg/l | – µmol/L | › | |||
| 5980 | Amikacine Piek Amukin | Serum |
– | 3319-1 µg/ml | – µmol/L | › | ||||
| 6003 | Amisulpride | Serum |
256 (10,6) | – | 85384-6 µg/L | – | › | |||
| 7031 | Aminozuren kwantitatief | Urine |
1× per 1–2 weken | 215 (9) | – | 74991-1 | – | › | ||
| 8298 | Antidepress.opsporen/id. | Urine |
381 (15,9) | – | 19312-8 | – | › | |||
| 8437 | Andere PCR testen | EDTA |
– | – | – | › | ||||
| 8441 | Aangeraden DNA test VF | EDTA |
– | – | – | › | ||||
| 8452 | AR congenitale ichtiose | EDTA |
1× per 3 weken | – | – | – | › | |||
| 8465 | Adenovirus reptiel | Varia / Diversen |
– | – | – | › | ||||
| 8470 | Avipoxvirus PCR | Varia / Diversen |
1× per week | – | – | – | › | |||
| 8515 | Abortus profiel Paard | EDTA Respiratoir monster eSwab (Wissers varia / Overig) |
– | – | – | › | ||||
| 8521 | Agouti (A) | EDTA |
– | – | – | › | ||||
| 8522 | Appaloosa patroon 1 | EDTA |
– | – | – | › | ||||
| 8563 | Algemene screening PAARD | EDTA Serum |
25 (1,1) | – | – | – | › | |||
| 8582 | Albumine (CSV/S) | Serum |
65 (2,7) | – | – | – | › | |||
| 21220 | APTT APTT | Citraat |
maandag t/m vrijdag | 2 (0,1) | B | 14979-9 sec | 3173-2 sec | › | ||
| 21222 | APTT | Citraat |
2 (0,1) | – | – sec | – | › | |||
| 21310 | Antitrombine ATIII | Citraat |
2× per week, voorzien op dinsdag en vrijdag | 90 (3,8) | – | 27811-9 % | – | › | ||
| 21339 | APC resistentie APC resistentie | Citraat |
2× per week, voorzien op dinsdag en vrijdag | 95 (4) | – | 48591-2 | – | › |
